Sign In
Buy BCDA
$0.87
-0.0256 (-2.84%)
At Close: Jun 03, 2026
BioCardia's stock pulls back after taking advantage of recent doubling with another share sale
09:55am, Wednesday, 16'th Dec 2020
Shares of BioCardia Inc. sank 13.9% in morning trading Wednesday, after the developer of regenerative biologic therapies announced more stock sales in the wake of the 137.6% rocket ride over the past
BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
08:30am, Wednesday, 16'th Dec 2020
SAN CARLOS, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA) (BioCardia or the “Company”) today announced it has entered into definitive agreements with investors for th
BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules [Revised]
01:21am, Tuesday, 15'th Dec 2020
SAN CARLOS, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA)(BioCardia or the “Company”) today announced it has entered into definitive agreements with investors for the
BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
03:21pm, Monday, 14'th Dec 2020
SAN CARLOS, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA)(BioCardia or the “Company”) today announced it has entered into definitive agreements with investors for the
BioCardia News: Why BCDA Stock Is Soaring Today
01:37pm, Monday, 14'th Dec 2020
BioCardia (BCDA) news for Monday includes an announcement concerning interim clinical trial results boosting BCDA stock higher. The post BioCardia News: Why BCDA Stock Is Soaring Today appeared first
Why BioCardia, Pacific Biosciences And HCA Are Trading Higher Today
12:23pm, Monday, 14'th Dec 2020
BioCardia (NASDAQ: BCDA) shares are trading higher. The company said it anticipates data safety monitoring board verbal feedback by the end of Dec. 15 for its pivotal Phase 3 CardiAMP Heart Failure Tr
SAN CARLOS, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] today announced that the Company's proprietary Helix Biotherapeutic Delivery System (the Helix System) demonstra
BioCardia Reports Third Quarter 2020 Financial Results and Business Highlights
07:00am, Tuesday, 10'th Nov 2020
SAN CARLOS, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of autologous and allogenic cell therapies, today reported financial results and bu
12 Healthcare Stocks Moving In Thursday's After-Market Session
12:00am, Thursday, 22'nd Oct 2020
Gainers
Cassava Sciences (NASDAQ:SAVA) stock rose 20.61% to $10.65 during Thursday's after-market session. Today's trading volume for this security ended up closing at 271...
BioCardia (NASDAQ:BCDA) Coverage Initiated by Analysts at Alliance Global Partners
03:26am, Tuesday, 22'nd Sep 2020
Alliance Global Partners initiated coverage on shares of BioCardia (NASDAQ:BCDA) in a report released on Monday morning, Stock Target Advisor reports. The brokerage issued a buy rating and a $11.50 pr
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
11:00am, Thursday, 13'th Aug 2020
SAN CARLOS, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reporte
BioCardia, Inc. (BCDA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
04:30pm, Wednesday, 12'th Aug 2020
BioCardia, Inc. (BCDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020
12:00pm, Friday, 07'th Aug 2020
SAN CARLOS, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced
LD Micro - Announces Preliminary List of Presenters for the LD-500.
03:15pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
Innate Pharma (OTCMKTS:IPHYF) & BioCardia (OTCMKTS:BCDA) Financial Contrast
03:00am, Tuesday, 04'th Aug 2020
Innate Pharma (OTCMKTS:IPHYF) and BioCardia (OTCMKTS:BCDA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their ana
